Joel Greenblatt Protagonist Therapeutics, Inc Transaction History
Gotham Asset Management, LLC
- $11.5 Billion
- Q1 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 23,072 shares of PTGX stock, worth $1.18 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,072Holding current value
$1.18 Million% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding PTGX
# of Institutions
304Shares Held
61.4MCall Options Held
1.01MPut Options Held
555K-
Farallon Capital Management LLC San Francisco, CA6.11MShares$312 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$294 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.72MShares$292 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$218 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$153 Million5.07% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.51B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...